RhumbLine Advisers’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-68,062
| Closed | -$5.12M | – | 3092 |
|
|
2022
Q2 | $5.12M | Buy |
68,062
+8,552
| +14% | +$644K | 0.01% | 1229 |
|
|
2022
Q1 | $1.6M | Sell |
59,510
-4,644
| -7% | -$125K | ﹤0.01% | 1922 |
|
|
2021
Q4 | $3.06M | Sell |
64,154
-1,615
| -2% | -$77K | ﹤0.01% | 1640 |
|
|
2021
Q3 | $4.37M | Buy |
65,769
+1,773
| +3% | +$118K | 0.01% | 1436 |
|
|
2021
Q2 | $4.99M | Buy |
63,996
+20,541
| +47% | +$1.6M | 0.01% | 1427 |
|
|
2021
Q1 | $4.11M | Sell |
43,455
-3,366
| -7% | -$318K | 0.01% | 1518 |
|
|
2020
Q4 | $5.71M | Buy |
46,821
+5,881
| +14% | +$717K | 0.01% | 1281 |
|
|
2020
Q3 | $3.58M | Sell |
40,940
-1,540
| -4% | -$135K | 0.01% | 1358 |
|
|
2020
Q2 | $2.74M | Buy |
42,480
+6,091
| +17% | +$393K | ﹤0.01% | 1554 |
|
|
2020
Q1 | $1.63M | Buy |
36,389
+2,555
| +8% | +$114K | ﹤0.01% | 1655 |
|
|
2019
Q4 | $2.11M | Buy |
33,834
+27,105
| +403% | +$1.69M | ﹤0.01% | 1775 |
|
|
2019
Q3 | $253K | Buy |
6,729
+911
| +16% | +$34.3K | ﹤0.01% | 2659 |
|
|
2019
Q2 | $237K | Buy |
+5,818
| New | +$237K | ﹤0.01% | 2721 |
|